Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Kidney (Renal) Cancer

2 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCURO1514

08/06/2015

A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti-PD-L1 ANTIBODY) in Combination with BEVACIZUMAB versus SUNITINIB in Patients with Untreated Advanced Renal Cell Carcinoma.

Treatment

VICCMD1188

06/08/2012

An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers